The Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates.
APA
Nestor MS, Kleinfelder RE, Pickett A (2017). The Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates.. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 43 Suppl 3, S344-S362. https://doi.org/10.1097/DSS.0000000000001412
MLA
Nestor MS, et al.. "The Use of Botulinum Neurotoxin Type A in Aesthetics: Key Clinical Postulates.." Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], vol. 43 Suppl 3, 2017, pp. S344-S362.
PMID
33065958
Abstract
[BACKGROUND] The most common aesthetic procedure performed worldwide is the injection of botulinum neurotoxin Type A (BoNT-A). Aesthetic providers must fully comprehend the objective scientific data, theoretical mechanisms of action, and differences between brands of BoNT-A.
[OBJECTIVE] To determine and review the relevant clinical postulates for the use of botulinum toxin in aesthetics.
[MATERIALS AND METHODS] The BoNT-A clinical postulates presented here discuss how each brand of BoNT-A acts identically, how the molecular potency may vary between the different products, how patient age, gender, genetics, and muscle mass cause variation in toxin receptor number and density, and how both practitioner and patient can affect toxin distribution.
[RESULTS] A total of 8 clinical postulates have been identified that are key to understanding the use of botulinum toxin in aesthetics and to obtaining the best clinical results.
[CONCLUSION] All of these factors affect the potential efficacy of the injected toxin and hence the aesthetic results obtained.
[OBJECTIVE] To determine and review the relevant clinical postulates for the use of botulinum toxin in aesthetics.
[MATERIALS AND METHODS] The BoNT-A clinical postulates presented here discuss how each brand of BoNT-A acts identically, how the molecular potency may vary between the different products, how patient age, gender, genetics, and muscle mass cause variation in toxin receptor number and density, and how both practitioner and patient can affect toxin distribution.
[RESULTS] A total of 8 clinical postulates have been identified that are key to understanding the use of botulinum toxin in aesthetics and to obtaining the best clinical results.
[CONCLUSION] All of these factors affect the potential efficacy of the injected toxin and hence the aesthetic results obtained.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 |
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
같은 제1저자의 인용 많은 논문 (5)
- A Novel Injectable Polypeptide Nanoparticle Encapsulated siRNA Targeting TGF-β1 and COX-2 for Localized Fat Reduction II: Phase I Clinical Trial.
- Botulinum toxin-induced blepharoptosis: Anatomy, etiology, prevention, and therapeutic options.
- Treatment options for androgenetic alopecia: Efficacy, side effects, compliance, financial considerations, and ethics.
- "Masking" our emotions: Botulinum toxin, facial expression, and well-being in the age of COVID-19.
- Rethinking the Journal Impact Factor and Publishing in the Digital Age.
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.